Retatrutide 99% API raw material klow80 TDS metabolism research peptides
TDS 155 Inquiries
49557-75-7
Pharmaceutical Grade
99%
ShenZhen
No Brand
5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
Yes
2026-10-09
Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCopper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found also in saliva and urine.
ChEBI: Gly-His-Lys is a tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence. It has a role as a metabolite, a chelator, a vulnerary and a hepatoprotective agent.CertificatesBasic Info-
Product Name:
Copper Peptide
Other Name:GHK Cu Copper Peptide;L-Lysine,glycyl-L-histidyl-;Copper Peptide powder (GHK-cu);GHK Cu Copper Peptide GHK.Cu GHK-Cu;Liver Cell Growth Factor(GHK);GHKcu/Growth-Modulating peptide;(Gly-His-Lys)2Cu.xHAc;AHK-Cu (Copper Peptide)
CAS No.:49557-75-7
Molecular Formula:C14H24N6O4
InChIKeys:MVORZMQFXBLMHM-QWRGUYRKSA-N
Molecular Weight:340.38
EC Number:1592732-453-0
Color/Form:Off-White
Categories:
Characteristics-
Density:
1.324
Melting Point:>144°C (dec.)
Boiling Point:831.0±65.0 °C(Predicted)
PKA:3.11±0.10(Predicted)
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU
-
Location:
18 Linchang, Wujin district, Changzhou, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History155 Inquiries
Country Product Purchase Quantity Date Posted
Australia
GHK-CU, Retatrutide
20 PCS Oct 18, 2026
Norway
GHKCU cosmetic grade
3 G Oct 12, 2026
Romania
GHK-Cu
1 G Oct 9, 2026
China
cu100
100 G Oct 5, 2026
Canada
Ghk cu
20 MG Oct 5, 2026
United States
GhkCu
20 MG Oct 5, 2026
Russia
Peptides
1 G Sep 26, 2026
United States
ghkcu
100 G Sep 20, 2026
United States
Glow
10 PCS Sep 12, 2026
United States
GHK-Cu Blue Copper Peptide
100 MG Aug 31, 2026
Brazil
Ghk cu
5 MT Aug 26, 2026
Bulgaria
copper peptide
250 G Aug 13, 2026
Germany
GHK CU
100 MG Aug 12, 2026
Australia
Copper peptide
1 MT Aug 10, 2026
Malta
Copper peptide GHK-CU
1000 MT Aug 8, 2026
China
Ghk-Cu
1 MT Aug 6, 2026
Russia
GHK-Cu
50 MG Aug 6, 2026
United States
copper-peptide ghk-cu
20 MT Jul 26, 2026
United Kingdom
ghk-cu
100 MG Jul 23, 2026
United States
Ghk-cu
20 MT Jul 17, 2026 Post an enquiry for this product
More from this Seller
-
-
-
SS-31 Preserve mitochondrial membrane potential and protect damaged mitochondria
Pharmaceutical Grade / 99%
$8-9/G FOB
-
-
-
-
NAD+ impacts on aging, energy status, sleep quality and metabolic regulation
Pharmaceutical Grade / 99%
$9-10/G FOB
-
-
-
-
CAS 89030-95-5 Peptide Raw Material Copper Tripeptide-1 Blue Powder
Pharmaceutical Grade / 99%
$30-38/UNIT FOB
-
-
-
-
Cagrilintide, Alleviate chronic low-grade inflammation and decrease the level of obesity-related inflammatory markers
Pharmaceutical Grade / 99%
$8-9/G FOB
-
-
-
-
KPV White to off-white lyophilized loose powder Anti-inflammation Relieve red and sensitive skin, improve inflammatory acne
Pharmaceutical Grade / 99%
$11-12/G FOB
-
-
-
-
SLU-PP-332 Boost metabolism Reduce fat accumulation Increase muscle mass
Pharmaceutical Grade / 99%
$7/G FOB
-
